PCV40 COST-EFFECTIVENESS ANALYSIS OF PRASUGREL, CLOPIDOGREL AND TICAGRELOR IN DUAL ANTIPLATELET THERAPY ON PATIENTS WITH ACUTE CORONARY SYNDROME IN AUSTRIA BETWEEN 2009 AND 2014

Autor: Marchev, S., Sheikh Rezaei, S., Geroldinger, A., Heinze, G., Reichardt, B., Wolzt, M.
Zdroj: In Value in Health May 2020 23 Supplement 1:S97-S97
Databáze: ScienceDirect